Science

Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.

Research & Development

NOSIS™

Partners

Evidence

The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers

Read More →

Platform

Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.

Sepsis ImmunoScore®

Clinical Trials

Pipeline

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Read More →

Resources

Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.

Newsroom

Resource Library

Events

Why We Call It an “AI-Biomarker”

Read More →

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore Outperforms Conventional Sepsis Tools

Read More →

About

As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.

Mission, Vision & Values

Careers

Leadership

Investors

Awards

Prenosis and Winners of the Chicago Innovation Awards Ring the Opening Nasdaq Bell

Read More →

Interpretability of an FDA-authorized AI/ML sepsis diagnostic tool improved by SHAP values

Article originally published February 2026 in JAMIA OPEN

SUMMARY | Interpretability of an FDA-authorized AI/ML sepsis diagnostic tool improved by SHAP values

Artificial intelligence (AI) tools in healthcare have the potential to improve patient care, but they often operate as “black boxes,” giving answers without explaining how they arrived at them. This lack of transparency makes clinicians hesitant to use them. This study investigated whether adding explanations to an FDA-authorized AI tool for detecting sepsis would help clinicians better understand and trust the technology. We showed 30 clinicians real patient cases using the AI tool. The tool included explanations called SHAP values that show how much each patient characteristic (vitals, labs, etc.) influenced the model’s sepsis risk assessment. We tested whether clinicians could understand these explanations and if they found them helpful. We found clinicians correctly interpreted the explanations 98% of the time, and in every case said they improved their understanding of how the AI generated sepsis risk scores. All 30 clinicians preferred having the explanations versus not having them. These results indicate that SHAP values are a valuable approach to making AI medical tools more transparent, which could help overcome clinician hesitation to use them. This could lead to better adoption of AI tools in patient care and may enhance the impact of this particular AI tool on sepsis care.

Read the full article in JAMIA OPEN.